AKOYA BIOSCIENCES INC

Akoya Reports 53% Revenue Growth in the Second Quarter of 2021

10 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

Akoya Biosciences to Present at the Canaccord 41st Annual Growth Conference

03 Aug 2021 08:05:00 By Nasdaq GlobeNewswire

Akoya to Report Second Quarter 2021 Financial Results on August 10, 2021

20 Jul 2021 08:05:00 By Nasdaq GlobeNewswire

Akoya Announces Publication of the MITRE Study, the First Multi-Institutional Analytical Demonstration of a Spatial Biology Workflow, in the Journal for ImmunoTherapy of Cancer

19 Jul 2021 08:05:00 By Nasdaq GlobeNewswire

Akoya to Partner with Nikon, CrestOptics and Andor to Enable New Spatial Biology Applications through the Imaging Innovators (I2) Network

29 Jun 2021 08:05:00 By Nasdaq GlobeNewswire

Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of Directors

25 Jun 2021 08:05:00 By Nasdaq GlobeNewswire

Akoya to Help Support Leading Philanthropic Organization with Spatial Phenotyping Capabilities

15 Jun 2021 08:05:00 By Nasdaq GlobeNewswire

Akoya Announces Publication of New Immunotherapy Biomarker Signature in Science, Leveraging Principles of Astronomy and Pathology

10 Jun 2021 14:00:00 By Nasdaq GlobeNewswire

Akoya Set to Join Russell 3000® Index

09 Jun 2021 08:02:00 By Nasdaq GlobeNewswire

Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune Biology

04 Jun 2021 08:05:00 By Nasdaq GlobeNewswire

Akoya Announces Rollout of Strategic Clinical Research Program to Advance Adoption of Spatial Biology for Clinical Applications

02 Jun 2021 08:05:00 By Nasdaq GlobeNewswire

Akoya Reports First Quarter 2021 Financial Results and Issues Full Year 2021 Guidance

18 May 2021 16:05:00 By Nasdaq GlobeNewswire

Akoya and ZEISS to Co-Market Innovative CODEX® Spatial Biology Workflow

17 May 2021 08:05:00 By Nasdaq GlobeNewswire